IFT81 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.691000E-01
Normal-vs-Stage2
7.094800E-01
Normal-vs-Stage3
2.918000E-01
Normal-vs-Stage4
8.639200E-01
Stage1-vs-Stage2
1.820390E-02
Stage1-vs-Stage3
5.289600E-02
Stage1-vs-Stage4
2.541600E-01
Stage2-vs-Stage3
1.395820E-01
Stage2-vs-Stage4
8.787000E-01
Stage3-vs-Stage4
8.346000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.575400E-01
Normal-vs-AfricanAmerican
7.778200E-01
Normal-vs-Asian
4.441800E-01
Caucasian-vs-AfricanAmerican
7.327600E-01
Caucasian-vs-Asian
1.985010E-01
AfricanAmerican-vs-Asian
4.954000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.131200E-01
Normal-vs-Female
9.216000E-01
Male-vs-Female
9.576200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.778000E-01
Normal-vs-Age(41-60Yrs)
6.959400E-01
Normal-vs-Age(61-80Yrs)
6.994800E-01
Normal-vs-Age(81-100Yrs)
7.317600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.625400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.793800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.293600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.121400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.621600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.640800E-01
Normal-vs-Daily Drinker
5.910000E-01
Normal-vs-Weekly Drinker
5.911400E-01
Normal-vs-Occasional Drinker
8.393200E-01
Normal-vs-Social Drinker
6.720800E-01
Non Drinker-vs-Daily Drinker
8.568000E-01
Non Drinker-vs-Weekly Drinker
9.396400E-01
Non Drinker-vs-Occasional Drinker
1.209010E-01
Non Drinker-vs-Social Drinker
9.570300E-02
Daily Drinker-vs-Weekly Drinker
9.353400E-01
Daily Drinker-vs-Occasional Drinker
1.709820E-01
Daily Drinker-vs-Social Drinker
1.175180E-01
Weekly Drinker-vs-Occasional Drinker
2.206400E-01
Weekly Drinker-vs-Social Drinker
1.212180E-01
Occasional Drinker-vs-Social Drinker
6.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.124200E-01
Normal-vs-Grade 2
9.734000E-02
Normal-vs-Grade 3
7.442300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.153800E-01
Grade 1-vs-Grade 3
4.962800E-01
Grade 1-vs-Grade 4
3.124200E-01
Grade 2-vs-Grade 3
1.859780E-01
Grade 2-vs-Grade 4
9.734000E-02
Grade 3-vs-Grade 4
7.442300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.094200E-01
Normal-vs-NonDiabetic
9.772800E-01
Diabetic-vs-NonDiabetic
2.116400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.648400E-01
Normal-vs-NoPancreatitis
8.650000E-01
Pancreatitis-vs-NoPancreatitis
6.818600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.609000E-01
Normal-vs-N1
7.616200E-01
N0-vs-N1
4.001600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.406200E-01
Normal-vs-TP53-NonMutant
7.420600E-01
TP53-Mutant-vs-TP53-NonMutant
1.199160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
